Islet Management’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-25,733
Closed -$2.61M 169
2022
Q1
$2.61M Sell
25,733
-23,310
-48% -$2.59M 0.11% 99
2021
Q4
$7.22M Buy
49,043
+9,649
+24% +$2.16M 0.2% 129
2021
Q3
$9.87M Buy
39,394
+28,500
+262% +$9.79M 0.21% 124
2021
Q2
$5.04M Hold
10,894
0.14% 130
2021
Q1
$5.35M Buy
+10,894
New +$5.66M 0.13% 135

Other funds holding WGS

Islet Management's WGS Position: Q2 2022 in Review

Islet Management sold out of GeneDx Holdings (WGS) in Q2 2022, closing a stake of 25,733 shares — an estimated $2.61M sold.

Islet Management first reported a position in WGS in Q1 2021 and held it in 5 quarters. The position peaked at $9.87M in Q3 2021. 111 funds tracked by Wall St. Rank hold WGS as of Q2 2022.

  • Islet Management reported no remaining GeneDx Holdings position as of Q2 2022 after selling out during the quarter.
  • Islet Management sold 25,733 GeneDx Holdings shares in Q2 2022, an estimated $2.61M.
  • Islet Management first reported a position in GeneDx Holdings in Q1 2021 and held it in 5 quarters.
  • Islet Management's GeneDx Holdings position peaked at $9.87M in Q3 2021.
  • 111 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2022.

Based on Islet Management's 13F filing for Q2 2022, filed 15 Aug 2022.